Kuno Sommer
Chairman at BACHEM HOLDING AG
Net worth: 4 M $ as of 29/04/2024
Network origin in Kuno Sommer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
36
| Subsidiary | Pharmaceuticals: Major | 36 |
| Public Company | Pharmaceuticals: Major | 26 | |
25
| Public Company | Pharmaceuticals: Major | 25 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.
13
| Private Company | Biotechnology | 13 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Sunstar-Holding AG
 Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland.
7
| Private Company | Hotels/Resorts/Cruise lines | 7 |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland
5
| Extinct | Miscellaneous Commercial Services | 5 |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
| Public Company | Food: Specialty/Candy | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kuno Sommer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chairman | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Chairman Corporate Officer/Principal General Counsel Corporate Secretary Corporate Officer/Principal Chairman | |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member Sales & Marketing Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of St. Gallen | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| MFC Beteiligungs AG | Chairman Chairman Director/Board Member | ||
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member Chairman | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| ACTELION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| University of Bocconi | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal | ||
| Friends of Phelophepa Foundation | Chairman Chairman | ||
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Investment Managers | Founder Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Private Equity Analyst Corporate Officer/Principal | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Chairman | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree | |
| InterMune International AG | Director of Finance/CFO Corporate Officer/Principal | ||
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman Chief Executive Officer | |
| University of Innsbruck | College/University | Doctorate Degree Doctorate Degree | |
| University of Bern | College/University | Corporate Officer/Principal Graduate Degree | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DOTTIKON ES HOLDING AG | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Ingro Finanz AG
 Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The company is based in Bubendorf, Switzerland. | Financial Conglomerates | Chairman Director/Board Member | |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Founder Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| University of Applied Sciences Basel | College/University | Graduate Degree Undergraduate Degree | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chairman Compliance Officer | |
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal |
Statistics
International
| Switzerland | 24 |
| United States | 11 |
| Germany | 8 |
| United Kingdom | 3 |
| Italy | 3 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 402 |
| Corporate Officer/Principal | 188 |
| Chairman | 107 |
| Chief Executive Officer | 70 |
| Independent Dir/Board Member | 66 |
Most connected contacts
| Insiders | |
|---|---|
| Franz Humer | 45 |
| Argeris Karabelas | 42 |
| Jean-Luc Bélingard | 40 |
| Peter Morgan Kash | 32 |
| Erich Maximilian Platzer | 31 |
| Dennis Ausiello | 26 |
| Leonard Patrick Gage | 26 |
| Gottlieb A. Keller | 26 |
| Silvio Inderbitzin | 25 |
| Severin Schwan | 23 |
| Pamela Kirby | 22 |
| Herbert Conrad | 21 |
| Richard T. Laube | 21 |
| Patrick Baeuerle | 19 |
| Ulrich Winzenried | 18 |
- Stock Market
- Insiders
- Kuno Sommer
- Company connections
